These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11064307)

  • 1. Chapter 4. The ethics of setting limits on ICD therapy.
    Hoffmaster B
    Can J Cardiol; 2000 Oct; 16(10):1313-8. PubMed ID: 11064307
    [No Abstract]   [Full Text] [Related]  

  • 2. Chapter 5. Legal implications of ICD therapy.
    Dickens BM
    Can J Cardiol; 2000 Oct; 16(10):1319-24. PubMed ID: 11064308
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter/defibrillator therapy: the meaning of terms.
    Smith ER
    Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
    [No Abstract]   [Full Text] [Related]  

  • 4. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing.
    Simpson CS; Hoffmaster B; Dorian P
    Can J Cardiol; 2005 May; 21(7):595-9. PubMed ID: 15940358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of a randomized trial of biventricular pacing in Canada.
    Bentkover JD; Dorian P; Thibault B; Gardner M
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical approaches to setting limits.
    Callahan D
    Pride Inst J Long Term Home Health Care; 1993; 12(2):5-9. PubMed ID: 10126838
    [No Abstract]   [Full Text] [Related]  

  • 7. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system.
    Gillis AM
    Can J Cardiol; 2005 May; 21 Suppl A():25A-30A. PubMed ID: 15953941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
    Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
    Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac rehabilitation in patients with implantable defibrillators. Feasibility and complications.
    Kamke W; Dovifat C; Schranz M; Behrens S; Moesenthin J; Völler H
    Z Kardiol; 2003 Oct; 92(10):869-75. PubMed ID: 14579052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
    Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
    Kozák M; Krivan L; Semrád B
    Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic home monitoring of implantable cardioverter defibrillators.
    Nielsen JC; Kottkamp H; Zabel M; Aliot E; Kreutzer U; Bauer A; Schuchert A; Neuser H; Schumacher B; Schmidinger H; Stix G; Clémenty J; Danilovic D; Hindricks G
    Europace; 2008 Jun; 10(6):729-35. PubMed ID: 18434298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caring for unhealthy lifestyles.
    Alibhai SM
    CMAJ; 1994 Sep; 151(5):508-9; author reply 510-1. PubMed ID: 8069787
    [No Abstract]   [Full Text] [Related]  

  • 15. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy.
    Alsheikh-Ali AA; Homer M; Maddukuri PV; Kalsmith B; Estes NA; Link MS
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):784-9. PubMed ID: 18284493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoidance behaviors in patients with implantable cardioverter defibrillators.
    Lemon J; Edelman S; Kirkness A
    Heart Lung; 2004; 33(3):176-82. PubMed ID: 15136777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
    Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients.
    Leosdottir M; Sigurdsson E; Reimarsdottir G; Gottskalksson G; Torfason B; Vigfusdottir M; Eggertsson S; Arnar DO
    Europace; 2006 Mar; 8(3):168-74. PubMed ID: 16627433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of wireless capsule endoscopy in patients with implantable cardiac defibrillators.
    Leighton JA; Srivathsan K; Carey EJ; Sharma VK; Heigh RI; Post JK; Erickson PJ; Robinson SR; Bazzell JL; Fleischer DE
    Am J Gastroenterol; 2005 Aug; 100(8):1728-31. PubMed ID: 16086708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators.
    Dolenc TJ; Barnes RD; Hayes DL; Rasmussen KG
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1257-63. PubMed ID: 15461716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.